EF
LGND icon

Empowered Funds’s Ligand Pharmaceuticals LGND Stock Holding History

Empowered Funds’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
3,593
+1,053
+41% +$248K 0.01% 1423
2026
Q1 		$507K Buy
+2,540
New +$503K ﹤0.01% 1638
2018
Q4 		– Sell
-10,572
Closed -$1.81M – 102
2018
Q3 		$1.81M Buy
+10,572
New +$1.59M 0.53% 59

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's LGND Position: Q2 2026 in Review

Empowered Funds increased its Ligand Pharmaceuticals (LGND) stake by 41% in Q2 2026, buying an estimated $248K and bringing the position to 3,593 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1423.

Empowered Funds first reported a position in LGND in Q3 2018 and has held it in 3 quarters since. The position peaked at $1.81M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Empowered Funds held 3,593 shares of Ligand Pharmaceuticals worth $1.14M as of Q2 2026.
  • Empowered Funds bought 1,053 Ligand Pharmaceuticals shares in Q2 2026, an estimated $248K.
  • Ligand Pharmaceuticals made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1423 holding.
  • Empowered Funds first reported a position in Ligand Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • Empowered Funds's Ligand Pharmaceuticals position peaked at $1.81M in Q3 2018.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.